Jazz Pharmaceuticals PLC (JAZZ) To Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) FY 2026 Other Release

Newsdesk: